Constellium SE

NYSE:CSTM Rapport sur les actions

Capitalisation boursière : US$2.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Constellium Croissance future

Future contrôle des critères 4/6

Constellium devrait augmenter ses bénéfices et ses revenus de 42% et de 10.3% par an respectivement, tandis que le BPA devrait croître de croître de 41.5% par an.

Informations clés

42.0%

Taux de croissance des bénéfices

41.5%

Taux de croissance du BPA

Metals and Mining croissance des bénéfices21.4%
Taux de croissance des recettes10.3%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour29 Jul 2024

Mises à jour récentes de la croissance future

Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts

Apr 28
Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts

Recent updates

Why We're Not Concerned About Constellium SE's (NYSE:CSTM) Share Price

May 21
Why We're Not Concerned About Constellium SE's (NYSE:CSTM) Share Price

We Think That There Are More Issues For Constellium (NYSE:CSTM) Than Just Sluggish Earnings

May 01
We Think That There Are More Issues For Constellium (NYSE:CSTM) Than Just Sluggish Earnings

Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts

Apr 28
Earnings Miss: Constellium SE Missed EPS By 46% And Analysts Are Revising Their Forecasts

Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate

Apr 16
Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate

Is Constellium (NYSE:CSTM) Using Too Much Debt?

Mar 29
Is Constellium (NYSE:CSTM) Using Too Much Debt?

Constellium (NYSE:CSTM) Is Doing The Right Things To Multiply Its Share Price

Mar 11
Constellium (NYSE:CSTM) Is Doing The Right Things To Multiply Its Share Price

Constellium: Solid Fundamentals And Attractive Valuation, Despite Macro Headwinds

Jan 29

Constellium SE (NYSE:CSTM) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 08
Constellium SE (NYSE:CSTM) Shares Could Be 30% Below Their Intrinsic Value Estimate

Potential Upside For Constellium SE (NYSE:CSTM) Not Without Risk

Dec 18
Potential Upside For Constellium SE (NYSE:CSTM) Not Without Risk

Constellium (NYSE:CSTM) Use Of Debt Could Be Considered Risky

Nov 23
Constellium (NYSE:CSTM) Use Of Debt Could Be Considered Risky

Constellium: Sensitivity To Exogenous Factors Capping Upside Potential, Rate Hold

Oct 26

Are Investors Undervaluing Constellium SE (NYSE:CSTM) By 33%?

Sep 21
Are Investors Undervaluing Constellium SE (NYSE:CSTM) By 33%?

Constellium: Strong Q2 2023 Results Support Long-Term Investment Thesis

Aug 03

Here's Why Constellium (NYSE:CSTM) Is Weighed Down By Its Debt Load

Jul 27
Here's Why Constellium (NYSE:CSTM) Is Weighed Down By Its Debt Load

Constellium (NYSE:CSTM) Has No Shortage Of Debt

Apr 26
Constellium (NYSE:CSTM) Has No Shortage Of Debt

Here's Why We Think Constellium (NYSE:CSTM) Is Well Worth Watching

Mar 13
Here's Why We Think Constellium (NYSE:CSTM) Is Well Worth Watching

Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 23
Constellium SE (NYSE:CSTM) Shares Could Be 41% Below Their Intrinsic Value Estimate

Constellium Q4 2022 Earnings Preview

Feb 21

Constellium sells Ussel plant

Feb 03

Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

Jan 09
Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Constellium SE (NYSE:CSTM) Suggests It's 45% Undervalued

Nov 17
An Intrinsic Calculation For Constellium SE (NYSE:CSTM) Suggests It's 45% Undervalued

Constellium Q3 2022 Earnings Preview

Oct 25

Constellium supplying aluminium Auto Body Sheet solutions to car manufacturer

Sep 13

Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?

Sep 06
Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?

Constellium EPS of -€0.24, revenue of €2.28B beats by €240M

Jul 27

Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

Jul 25
Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?

May 31
Do Constellium's (NYSE:CSTM) Earnings Warrant Your Attention?

Constellium: A Discounted Play On Secular Aluminum Tailwinds

Apr 25

Constellium SE's (NYSE:CSTM) Intrinsic Value Is Potentially 97% Above Its Share Price

Mar 21
Constellium SE's (NYSE:CSTM) Intrinsic Value Is Potentially 97% Above Its Share Price

Constellium: An Overlooked Automotive Transformation Vehicle

Dec 30

Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

Dec 24
Does Constellium (NYSE:CSTM) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Constellium SE (NYSE:CSTM)

Sep 10
Calculating The Fair Value Of Constellium SE (NYSE:CSTM)

Constellium Is An Overlooked And Grossly Undervalued Opportunity

Aug 25

Here's Why Constellium (NYSE:CSTM) Has A Meaningful Debt Burden

Jul 10
Here's Why Constellium (NYSE:CSTM) Has A Meaningful Debt Burden

Constellium rising as it's set to join Russell 3000 index

Jun 08

Constellium (NYSE:CSTM) Is Posting Promising Earnings But The Good News Doesn’t Stop There

May 05
Constellium (NYSE:CSTM) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Calculating The Intrinsic Value Of Constellium SE (NYSE:CSTM)

Apr 29
Calculating The Intrinsic Value Of Constellium SE (NYSE:CSTM)

Constellium Q1 2021 Earnings Preview

Apr 27

Here's What Analysts Are Forecasting For Constellium SE (NYSE:CSTM) After Its Full-Year Results

Mar 01
Here's What Analysts Are Forecasting For Constellium SE (NYSE:CSTM) After Its Full-Year Results

Prévisions de croissance des bénéfices et des revenus

NYSE:CSTM - Estimations futures des analystes et données financières antérieures (EUR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20269,022N/A2305601
12/31/20257,9823112376245
12/31/20247,270226524954
6/30/20246,859161196545N/A
3/31/20247,014121190526N/A
12/31/20237,239125169506N/A
9/30/20237,470143130449N/A
6/30/20237,772209126449N/A
3/31/20238,097144118427N/A
12/31/20228,120301178451N/A
9/30/20227,982280173441N/A
6/30/20227,547247136378N/A
3/31/20226,790388107340N/A
12/31/20216,152257125357N/A
9/30/20215,689274138310N/A
6/30/20215,274196174330N/A
3/31/20214,78756108265N/A
12/31/20204,883-21152334N/A
9/30/20205,012-25143370N/A
6/30/20205,301-4498339N/A
3/31/20205,8085190459N/A
12/31/20195,90759176447N/A
9/30/20195,933-2069366N/A
6/30/20195,90019622332N/A
3/31/20195,836235-67222N/A
12/31/20185,686188-21166N/A
9/30/20185,536166-21843N/A
6/30/20185,387-29-18073N/A
3/31/20185,295-68N/A100N/A
12/31/20175,237-31N/A160N/A
9/30/20175,15030N/A157N/A
6/30/20175,07024N/A121N/A
3/31/20174,92117N/A211N/A
12/31/20164,743-4N/A88N/A
9/30/20164,704-414N/A212N/A
6/30/20164,764-474N/A252N/A
3/31/20164,910-530N/A440N/A
12/31/20155,153-554N/A368N/A
9/30/20154,967-141N/A334N/A
6/30/20154,635-85N/A330N/A
3/31/20154,176-10N/A228N/A
12/31/20143,66651N/A173N/A
9/30/20143,536100N/A227N/A
6/30/20143,471130N/A231N/A
3/31/20143,467126N/A227N/A
12/31/20133,49594N/A184N/A
9/30/20133,503123N/A266N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CSTM ( 42% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de CSTM ( 42% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).

Croissance élevée des bénéfices: Les bénéfices de CSTM devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CSTM ( 10.3% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CSTM ( 10.3% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de CSTM devrait être élevé dans 3 ans

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y